In the last trading session, 1.55 million shares of the Vincerx Pharma Inc (NASDAQ:VINC) were traded, and its beta was 1.55. Most recently the company’s share price was $0.28, and it changed around $0.02 or 7.34% from the last close, which brings the market valuation of the company to $1.44M. VINC currently trades at a discount to its 52-week high of $19.88, offering almost -7000.0% off that amount. The share price’s 52-week low was $0.22, which indicates that the current value has risen by an impressive 21.43% since then. We note from Vincerx Pharma Inc’s average daily trading volume that its 10-day average is 1.15 million shares, with the 3-month average coming to 1.12 million.
Vincerx Pharma Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended VINC as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Vincerx Pharma Inc is expected to report earnings per share of 0 for the current quarter.
Vincerx Pharma Inc (NASDAQ:VINC) trade information
Instantly VINC has showed a green trend with a performance of 7.34% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.2963 on recent trading dayincreased the stock’s daily price by 5.5%. The company’s shares are currently down -94.77% year-to-date, but still down -49.36% over the last five days. On the other hand, Vincerx Pharma Inc (NASDAQ:VINC) is -66.83% down in the 30-day period. We can see from the shorts that 0.14 million shares have been sold at a short interest cover period of 0.1 day(s).
The consensus price target as assigned by Wall Street analysts is $3, which translates to bulls needing to increase their stock price by 90.67% from its current value. Analyst projections state that VINC is forecast to be at a low of $2 and a high of $4.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -146.76%.
VINC Dividends
Vincerx Pharma Inc’s next quarterly earnings report is expected to be released on 2025-Mar-26.
Vincerx Pharma Inc (NASDAQ:VINC)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 4.11% of Vincerx Pharma Inc shares, and 4.06% of them are in the hands of institutional investors. The stock currently has a share float of 4.24%. Vincerx Pharma Inc stock is held by 25.0 institutions, with GOLDMAN SACHS GROUP INC being the largest institutional investor. By 2024-06-30, it held 2.9506% of the shares, which is about 0.63 million shares worth $0.51 million.
VANGUARD GROUP INC, with 2.932% or 0.63 million shares worth $0.51 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
